Brief: ImmunoGen Reports First Quarter 2023 Financial Results

ImmunoGen

28/04/2023 11:36

April 28 (Reuters) - Immunogen Inc  IMGN.O :
    * IMMUNOGEN REPORTS RECENT PROGRESS AND FIRST QUARTER 2023
FINANCIAL RESULTS
    * SEES FY OPERATING EXPENSES BETWEEN $320 MILLION AND $335
MILLION
    * EXPECTS TO PROVIDE ELAHERE PRODUCT REVENUE GUIDANCE LATER
THIS
YEAR
    * EXPECTS THAT ITS CURRENT CASH COMBINED WITH ANTICIPATED
PRODUCT
AND COLLABORATION REVENUES, WILL FUND OPERATIONS INTO 2025
    * Q1 EARNINGS PER SHARE VIEW $-0.25, REVENUE VIEW $20.5
MILLION --
REFINITIV IBES DATA
    * TOP-LINE RESULTS FROM CONFIRMATORY MIRASOL TRIAL
ANTICIPATED IN
EARLY MAY

Source text for Eikon:  ID:nBw65cW0Ha 
Further company coverage:  IMGN.O